1 / 8

U.S. Market for Hormone Replacement Therapy Expensive Human Growth Hormone Therapy Deters Uptake

U.S. Market for Hormone Replacement Therapy Expensive Human Growth Hormone Therapy Deters Uptake.

chibale
Télécharger la présentation

U.S. Market for Hormone Replacement Therapy Expensive Human Growth Hormone Therapy Deters Uptake

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Market for Hormone Replacement TherapyExpensive Human Growth Hormone Therapy Deters Uptake “Even as end users become increasingly conscious of the potential benefits of the human growth hormone (HGH), the high costs have posed a barrier to immediate adoption. The anti-aging use of HGH medications is not covered by any healthcare plans and this is limiting the acceptance of the therapy.” Pharmaceutical and Biotechnology Group

  2. Industry Trends • Side effects are a concern, particularly for estrogen replacement therapy (ERT) products, since recent World Health Initiative studies have linked oral formulations to increased risk of breast cancer. • In the HGH market, all products are injectable. However, novel formulations such as needle-free injection devices and products that may be administered just twice monthly are making these easier to take. This is important for the large pediatric segment of HGH patients, as they typically have trouble taking daily injectable drugs. • As healthcare and drug costs continue to rise, healthcare plan providers are continuing to restrict formulary inclusion and/or charging members higher co-payments for more expensive medications. Many managed care plans do not cover HGH products. • Direct-to-consumer (DTC) advertising has had a profound effect on stimulating the usage of hormone replacement therapy (HRT) drugs.

  3. Key Features • Frost & Sullivan Provides: • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analyst insights on ‘hot topics’ and emerging applications in the HRT market • Market sizing and competitive analysis • Market forecasts and opportunity analysis • Quarterly assessments • End-user analysis within each report

  4. What We Offer • Coverage: The United States • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans

  5. Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit market share opportunities New Entrants • Analyze challenges associated with the industry • Calculate forecasts for end-user growth potential • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of companies • Determine which participants will outperform the competition • Assess attractiveness of investing in the market

  6. What’s Included • Key statistics on potential and actual patients for the HRT markets • Challenges, trends and drivers in the HRT markets • Revenue forecast for HRT market from 2004-2010 • Other emerging products and technology in the market • Strategies for entry and growth

  7. Key Market Participants • Abbott • Berlex • Eli Lilly • Forest • Galen • Genentech • King • Mylan • Novartis • Pfizer • Serono • Wyeth

  8. For More Information • Call toll free: 877 GO FROST (877.463.7876) • Fax toll free: 888.690.3329 • E-mail: myfrost@frost.com • Visit: www.frost.com

More Related